SCHEMBL3674646

SCHEMBL3674646

Clc1ncncc1-c1ncnc2c1ncn2C1CCCCO1.Ic1ncnc2c1ncn2C1CCCCO1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.50
PI4KA P42356 4/20 0.47
PI4K2B Q8TCG2 4/20 0.47
PI4K2A Q9BTU6 4/20 0.47
PI4KB Q9UBF8 4/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
TP53 P04637 1/20 0.47
CYP2C9 P11712 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
APEX1 P27695 1/20 0.47
BLM P54132 1/20 0.47
ADCY1 Q08828 1/20 0.47
CYP1A2 P05177 2/20 0.46
TSHR P16473 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3643112 0.94 CYP2C19 (0.56) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL219612 0.83 CYP2C19 (0.68) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL5740769 0.80 PI4KA (0.71) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL115599 0.79 CYP2C19 (0.68) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL29683060 0.79 CYP2C19 (0.68) CYP2C19PI4KAPI4K2BPI4K2API4KB
Methane SCHEMBL10552077 0.78 CYP2C19 (0.67) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL1998927 0.75 PI4KA (0.71) CYP2C19PI4KAPI4K2BPI4K2API4KB
Methane SCHEMBL10551641 0.74 PI4KA (0.69) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL29878437 0.73 CYP2C19 (0.53) CYP2C19PI4KAPI4K2BPI4K2API4KB
SCHEMBL14964635 0.72 PI4KA (0.60) CYP2C19PI4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170887-A2 HETEROCYCLIC COMPOUNDS AS RAF KINASE MODULATORS Amgen Inc. (US) 2010-04-07 EP disclosed
WO-2008153947-A2 HETEROCYCLIC COMPOUNDS AS RAF KINASE MODULATORS AMGEN INC. (US) 2008-12-18 WO disclosed